
Thomas Ingraham
By Thomas Ingraham
Historically, funders had no reason to get involved with publishing: they were experts at funding research, publishers were experts at publishing research – why venture into a role that is already well-serviced by established professionals?
However, since the advent of online publishing and the open access movement, and the subsequent realization of potentially widespread irreproducibility and publication bias in the scholarly literature, the interests of funders are growing increasingly at odds with conventional scholarly publishing.
Funders (like ARC & NHMRC) are mandated to ensure maximum impact is achieved from the projects they fund. This means:
- Making research open access for reuse by anyone; not blocked by unaffordable paywalls.
- Ensuring new findings can be rapidly translated into new research or practical applications; not delayed by months or years due to lengthy embargo periods, or unnecessarily cumbersome peer review and production systems.
- Guaranteeing all valid work they fund is available for reuse, including data, code and negative results; not leaving these outputs to languish on a hard drive where no one can use it due to a novelty-obsessed editorial system or a data-shy research culture.
Further, funders want publishing to be as rigorous and transparent as possible, to ensure the system’s accountability and so build academic and public trust in the published literature, after it took a knock during the reproducibility crisis.
Several funders have implemented policies encouraging open access and data sharing but feel the progress has been too slow and the wider publishing system too resistant to change. There is also the issue of the cost effectiveness of current immediate open access options. Most are expensive and funders are worried costs could escalate further, especially for prestige and hybrid journals.
Some funders felt they couldn’t simply wait for the publishing system to realign itself with these goals; they need to get actively involved in kick-starting a better way of disseminating research.
So, in late 2016, Wellcome became the first funder to decisively move into the publishing game with the launch of Wellcome Open Research. Other major philanthropic and public funders have since launched their own open publishing platforms, namely: the Bill & Melinda Gates Foundation, Health Research Board Ireland, and most recently AMRC (a consortium of 24 UK-based biomedical charities). Earlier this year, the European Commission put out a tender to create its own platform, which would make it the biggest funder by far to move into this space.

Current funder-based publishing platforms
The platforms allow a funder’s grantees (and their collaborators) to openly share any research they think is fit to publish, along with any dependent raw data and code, within a few days of submission; referees openly review the work and if they deem it scientifically sound, the work is indexed. Articles can be updated if and when necessary.
The platform development and publishing work is contracted to an independent publisher, partially to make use of their expertise, partially to avoid potential funder conflicts of interest influencing editorial decisions. Currently, F1000Research is the sole provider of these platforms, but this may well change after the European Commission announces the results of its tender. However, the platform is owned by the funder and operates under its name; the latter is important as this endorsement helps ease their grantee’s minds, knowing anything they publish on the platform will be considered eligible for evaluations.
Funder publishing platforms are a still a very new development, and there are issues that need to be navigated carefully. These include but are not limited to preventing funder-editorial conflicts of interest; how smaller funders can get involved; who pays in joint-funder collaborations; avoiding vendor lock-in; and arranging long term governance of the platforms. These issues all look to be resolvable, and it will be exciting to see how much these platforms might disrupt the publishing ecosystem over the next few years.
Tom Ingraham is Scholarly Communications Officer at the University of Queensland. He was formerly an Associate Editor and Publisher at F1000Research, spending six years at the company from its inception in 2012 until early 2018 managing several of its publishing initiatives and community-based article collections.